|
TBPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82098999998992E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.75380000031222E-07 |
| Normal-vs-Stage2 |
5.147700E-02 |
| Normal-vs-Stage3 |
9.314300E-02 |
| Normal-vs-Stage4 |
7.460600E-01 |
| Stage1-vs-Stage2 |
7.304200E-02 |
| Stage1-vs-Stage3 |
8.882400E-03 |
| Stage1-vs-Stage4 |
6.285000E-03 |
| Stage2-vs-Stage3 |
7.144800E-01 |
| Stage2-vs-Stage4 |
3.084600E-01 |
| Stage3-vs-Stage4 |
4.169200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91591999999519E-05 |
| Normal-vs-AfricanAmerican |
1.639280E-03 |
| Normal-vs-Asian |
4.658300E-02 |
| Caucasian-vs-AfricanAmerican |
5.075000E-01 |
| Caucasian-vs-Asian |
8.221800E-01 |
| AfricanAmerican-vs-Asian |
9.886800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22420000026047E-07 |
| Normal-vs-Female |
9.216900E-03 |
| Male-vs-Female |
1.581800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.396250E-03 |
| Normal-vs-Extreme_Weight |
1.58170000430502E-08 |
| Normal-vs-Obese |
8.419100E-04 |
| Normal-vs-Extreme_Obese |
1.014680E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.588400E-02 |
| Normal_Weight-vs-Obese |
7.012000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.816010E-01 |
| Extreme_Weight-vs-Obese |
1.505750E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.015400E-01 |
| Obese-vs-Extreme_Obese |
7.674400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.968610E-01 |
| Normal-vs-Age(41-60Yrs) |
7.820500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.47530000005336E-06 |
| Normal-vs-Age(81-100Yrs) |
3.96810000002912E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.441600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.847700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.556200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.479600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.484100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.569700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.17339999938793E-08 |
| Normal-VS-Type2 PRCC |
3.56519999999971E-05 |
| Normal-VS-KIRP CIMP |
7.144200E-02 |
| Normal-VS-Unclassified PRCC |
7.441500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.738400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.51720000399303E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
8.365200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.8896000000066E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.657000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.174200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18589999997809E-06 |
| Normal-vs-N1 |
7.067400E-01 |
| Normal-vs-N2 |
2.388400E-02 |
| N0-vs-N1 |
1.84242999999862E-05 |
| N0-vs-N2 |
9.691000E-01 |
| N1-vs-N2 |
5.743700E-02 |
|
|
